13 October 2021

The Anti-Infective Pharmacology Working Group of the International Society of Antimicrobial Chemotherapy (ISAC) invites you to attend a free live roundtable discussion on Clinical Trials Targeting Antimicrobial Resistance on Wednesday 13 October 2021 at 17.00 Brisbane | 18.00 AEST | 15.00 Singapore | 08.00 UK.

Antimicrobials have been a cornerstone of modern medicine. However, antimicrobial resistance is now one of the most urgent global health threats. To combat the increasing antimicrobial resistance, optimising the clinical use of current antibiotics and development of new antibiotics are critical and require robust clinical trials using pharmacokinetic/ pharmacodynamic/toxicodynamic principles. In this ISAC online roundtable event, internationally leading clinicians and researchers will review the latest progress in clinical trials on antibiotics targeting antimicrobial resistance and discuss the challenges and opportunities.

Key Objectives

Join via Zoom (maximum 300 participants - first come first served)

Meeting ID: 814 1292 4364; Passcode: 368214

Email antiinfectives@ISAC.world for more information.

Presenters
Professor David Paterson
Director, University of Queensland Centre for Clinical Research
Clinical trials of new antibiotics: Innovations and challenges

Dr Mo Yin
Oxford Centre for Tropical Medicine and Global Health
Defining antibiotic treatment duration - experience from a multicentre randomised trial in Asia

Associate Professor David Lye
Director, Infectious Disease Research and Training Office, National Centre for Infectious Diseases, Singapore
Clinical trial networks to tackle AMR

15 minutes by each speaker followed by a 20-minute discussion

Moderators
Professor Jian Li
Biomedicine Discovery Institute, Monash University

Dr Jaime Lora-Tamayo
Department of Internal Medicine. Hospital Universitario 12 de Octubre
School of Medicine. Universidad Complutense. Madrid, Spain